Viewing Study NCT02011269


Ignite Creation Date: 2025-12-24 @ 11:10 PM
Ignite Modification Date: 2026-02-13 @ 5:27 AM
Study NCT ID: NCT02011269
Status: WITHDRAWN
Last Update Posted: 2015-05-06
First Post: 2013-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TSO for Plaque Psoriasis
Sponsor: Coronado Biosciences, Inc.
Organization:

Study Overview

Official Title: A Randomized, Blinded, Placebo-controlled Multicenter Study to Assess the Safety and Efficacy of Trichuris Suis Ova for the Treatment of Moderate to Severe Chronic Plaque Psoriasis
Status: WITHDRAWN
Status Verified Date: 2015-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Study not conducted
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This is a randomized, blinded, multicenter study to assess the safety and treatment effect of 12 weeks of Trichuris suis ova in subjects diagnosed with moderate to severe chronic plaque psoriasis.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
CNDO 201-201 OTHER Coronado Biosciences View